At a glance
- CDC offers training for public health partners on the importance of surveillance for vaccine-preventable diseases.
- Learn about upcoming training opportunities and how to take the training.
About the training
The 2025 CDC Training for Vaccine-Preventable Disease Surveillance includes:
- Session 1: Surveillance of Viral Vaccine-Preventable Diseases: January 28, 2025, from 3:00-4:30 PM ET
- Session 2: Surveillance of Bacterial Vaccine-Preventable Diseases: February 4, 2025, from 3:00-4:30 PM ET
- To receive continuing education credit (i.e., CEU, CME, CNE, and CPH) for the 2025 CDC Training for Vaccine-Preventable Disease Surveillance, please visit CDC TRAIN and search for the course in the Course Catalog using SCWCWD4893. Continuing education for this activity is pending, see final announcement for details.
- CDC, our planners, and content experts, wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
- Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.
- CDC did not accept financial or in-kind support from any ineligible company for this continuing education activity.
- CDC, our planners, and content experts, wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Course Objectives
- Identify the 3 main levels of the national surveillance system for vaccine-preventable diseases.
- Describe the concept of surveillance indicators (Session 2 only).
- Discuss the importance of case identification for surveillance.
- Describe appropriate mechanisms for surveillance.
- Describe the appropriate application of case definitions, including clinical description and case classification.
- List the most appropriate laboratory test(s) for surveillance.
- List epidemiologically important data to collect for surveillance.
- Describe one way that this educational activity will improve contributions as a team member.
Audiences
- Federal, state, tribal, local, and territorial public health professionals
- Health care providers including, but not limited to, epidemiologists, program managers, health educators, laboratorians, physicians, and nurses.